08/14/2014 - 12:11pm

The Food and Drug Administration has announced approval for Belsomra (suvorexant) tablets, which are used to treat insomnia.

08/14/2014 - 10:50am

High-dose influenza vaccine is 24% more effective than the standard-dose vaccine in protecting persons ages 65 and older against influenza illness and its complications, according to a Vanderbilt-led study published Wednesday in the New England Journal of Medicine.

08/13/2014 - 2:18pm

The majority of Americans report they have had a good year when it comes to their personal health, and are paying more attention to their health compared to just a few years ago, according to From Hope to Cures: PhRMA’s Second Annual National Health Survey. 

08/12/2014 - 10:08am

Rite Aid is getting a head start on the 2014-15 cold and flu season with the announcement Tuesday that seasonal flu shots are now available at Rite Aid pharmacies nationwide. 

 

08/11/2014 - 12:09pm

Janssen Pharmaceuticals received approval from the Food and Drug Administration for Invokamet, a fixed-dose therapy that combines canagliflozin and metformin hydrochloride in a single tablet.

08/11/2014 - 11:15am

Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million. 

08/08/2014 - 2:33pm

The Food and Drug Administration earlier this week announced approval for Orbactiv (oritavancin), an antibacterial drug used to treat patients with acute bacterial skin and skin structure infections.

08/08/2014 - 11:39am

The BBC on Tuesday reported that a team has developed an app and small lens add-on that allows blood-cell analysis via a smartphone.

08/07/2014 - 12:05pm

A new experimental drug to treat Ebola has been tried in the two American patients being treated in an Atlanta hospital, The New York Times reported Wednesday